TOQUELPA Trademark

Trademark Overview


On Wednesday, May 27, 2015, a trademark application was filed for TOQUELPA with the United States Patent and Trademark Office. The USPTO has given the TOQUELPA trademark a serial number of 86641990. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Tuesday, May 28, 2024. This trademark is owned by Glaxo Group Limited. The TOQUELPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardi...
toquelpa

General Information


Serial Number86641990
Word MarkTOQUELPA
Filing DateWednesday, May 27, 2015
Status710 - CANCELLED - SECTION 8
Status DateTuesday, May 28, 2024
Registration Number5332378
Registration DateTuesday, November 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe word(s) "TOQUELPA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateTuesday, May 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Saturday, May 30, 2015NEW APPLICATION ENTERED
Wednesday, December 2, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 8, 2015ASSIGNED TO EXAMINER
Wednesday, September 9, 2015NON-FINAL ACTION WRITTEN
Wednesday, September 9, 2015NON-FINAL ACTION E-MAILED
Wednesday, September 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 16, 2015ASSIGNED TO LIE
Friday, December 18, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 7, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, January 6, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 13, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 16, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 12, 2016SOU TEAS EXTENSION RECEIVED
Monday, September 12, 2016SOU EXTENSION 1 FILED
Monday, September 12, 2016SOU EXTENSION 1 GRANTED
Thursday, October 12, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 12, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, November 14, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 7, 2017SOU EXTENSION 2 FILED
Friday, April 7, 2017SOU EXTENSION 2 GRANTED
Tuesday, April 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, September 27, 2017TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, November 14, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 28, 2024CANCELLED SEC. 8 (6-YR)